Literature DB >> 20590827

Association of aldehyde dehydrogenase 2 gene polymorphism with pancreatic cancer but not colon cancer.

Kyoko Miyasaka1, Hiroko Hosoya, Yasuo Tanaka, Satoko Uegaki, Kenji Kino, Hiroshi Shimokata, Takako Kawanami, Akihiro Funakoshi.   

Abstract

AIMS: Most of the acetaldehyde, a recognized animal carcinogen, generated during alcohol metabolism is eliminated by liver mitochondrial aldehyde dehydrogenase 2 (ALDH2). More than 40% of Japanese people have the inactive form of ALDH2, and inactive ALDH2 is a risk factor for multiple cancer of the esophagus, as well as head and neck cancer. Possible associations between pancreatic cancer and ALDH2 gene polymorphism, as well as between colon cancer and ALDH2 gene polymorphism, in conjunction with smoking and/or drinking habits, were examined in a Japanese population.
METHODS: Patients with pancreatic cancer (n = 187) and with colon cancer (n = 49) were examined. The drinking (5 g ethanol consumption/day) and/or smoking habits as well as ALDH2 gene polymorphism were examined. The age-matched control subjects were recruited in the NILS Longitudinal Study of Aging (LSA).
RESULTS: Aging, smoking and inactive ALDH2, but not alcohol, are independent risk factors for pancreatic cancer. The frequency of smoking habits tended to be higher in patients with colon cancer compared with the patients without cancer. However, age, body mass index or the distribution of ALDH2 genotypes did not differ significantly among the patients with colon cancer, colon polyps and others.
CONCLUSIONS: Inactive ALDH2 is an independent risk factor for pancreatic cancer, but inactive ALDH2 might not be a risk for colon cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590827     DOI: 10.1111/j.1447-0594.2010.00616.x

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  10 in total

Review 1.  A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant.

Authors:  Eric R Gross; Vanessa O Zambelli; Bryce A Small; Julio C B Ferreira; Che-Hong Chen; Daria Mochly-Rosen
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-09-29       Impact factor: 13.820

2.  A critical analysis of the relationship between aldehyde dehydrogenases-2 Glu487Lys polymorphism and colorectal cancer susceptibility.

Authors:  Bo Chen; Kong-Wang Hu; Jia-Wei Zhang; Zhi-Jian Wei; Xiang-Ling Meng; Mao-Ming Xiong
Journal:  Pathol Oncol Res       Date:  2015-01-09       Impact factor: 3.201

3.  Association between Glu504Lys polymorphism of ALDH2 gene and cancer risk: a meta-analysis.

Authors:  Qiang Cai; Jian Wu; Qu Cai; Er-Zhen Chen; Zhao-Yan Jiang
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

Review 4.  ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective.

Authors:  Jeffrey S Chang; Jenn-Ren Hsiao; Che-Hong Chen
Journal:  J Biomed Sci       Date:  2017-03-03       Impact factor: 8.410

5.  Effect of ALDH2 polymorphism on cancer risk in Asians: A meta-analysis.

Authors:  Wei Zuo; Zhenyu Zhan; Lin Ma; Wei Bai; Shanggan Zeng
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

6.  Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.

Authors:  Wei-Lin Wang; Uyanga Batzorig; Chin-Sheng Hung; Po-Li Wei; Chien-Yu Huang; Yu-Jia Chang
Journal:  Biomed Res Int       Date:  2022-02-07       Impact factor: 3.411

Review 7.  Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.

Authors:  Jie Gao; Yue Hao; Xiangshu Piao; Xianhong Gu
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

8.  Meta-analysis of the aldehyde dehydrogenases-2 (ALDH2) Glu487Lys polymorphism and colorectal cancer risk.

Authors:  Hua Zhao; Kui-Jie Liu; Zhen-Dong Lei; San-Lin Lei; Yong-Quan Tian
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

9.  Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population.

Authors:  Xinping Ye; Xiangkun Wang; Liming Shang; Guangzhi Zhu; Hao Su; Chuangye Han; Wei Qin; Guanghui Li; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

10.  New insights into the genetic contribution of ALDH2 rs671 in pancreatic carcinogenesis: Evaluation by mediation analysis.

Authors:  Yuriko N Koyanagi; Isao Oze; Yumiko Kasugai; Yukino Kawakatsu; Yukari Taniyama; Kazuo Hara; Yasuhiro Shimizu; Issei Imoto; Hidemi Ito; Keitaro Matsuo
Journal:  Cancer Sci       Date:  2022-02-16       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.